In line with these observations, we recently showed that the combination of the HDACi VPA plus capecitabine synergizes with radiotherapy (RT) in CRC models, also confirming the modulation of both TS and TP protein levels by VPA even in the presence of RT [19,141] (Figure 4). The gene discussed is TYMP; the disease is colorectal carcinoma.